{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:56:23Z","timestamp":1792446983121,"version":"4.5.0"},"reference-count":163,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260605"],"award-info":[{"award-number":["82260605"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20224BAB206040"],"award-info":[{"award-number":["20224BAB206040"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20224BAB2116061"],"award-info":[{"award-number":["20224BAB2116061"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009102","name":"Education Department of Jiangxi Province","doi-asserted-by":"publisher","award":["GJJ2401808"],"award-info":[{"award-number":["GJJ2401808"]}],"id":[{"id":"10.13039\/501100009102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009102","name":"Education Department of Jiangxi Province","doi-asserted-by":"publisher","award":["GJJ2501802"],"award-info":[{"award-number":["GJJ2501802"]}],"id":[{"id":"10.13039\/501100009102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijbiomac.2026.151452","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T06:21:54Z","timestamp":1773728514000},"page":"151452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Role of astrocyte biomarker GFAP in early diagnosis and prognosis assessment of dementia: A comprehensive review"],"prefix":"10.1016","volume":"355","author":[{"given":"Shengxi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianrui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Bum","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wa","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.151452_bb0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1146\/annurev.publhealth.23.100901.140525","article-title":"The public health impact of Alzheimer\u2019s disease, 2000-2050: potential implication of treatment advances","volume":"23","author":"Sloane","year":"2002","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0010","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1016\/j.jpainsymman.2024.05.028","article-title":"Palliative care in early dementia","volume":"68","author":"de Sola-Smith","year":"2024","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: biology and pathology","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0020","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/cns.13123","article-title":"Astrocyte morphology: diversity, plasticity, and role in neurological diseases","volume":"25","author":"Zhou","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.31115","article-title":"Diagnostic performance of GFAP, UCH-L1, and MAP-2 within 30 and 60 minutes of traumatic brain injury","volume":"7","author":"Papa","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0030","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3390\/cells12091309","article-title":"GFAP as a potential biomarker for Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"12","author":"Kim","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0035","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1002\/alz.13898","article-title":"Serum NfL and GFAP as biomarkers of progressive neurodegeneration in TBI","volume":"20","author":"Shahim","year":"2024","journal-title":"Alzheimers Dement. J. Alzheimers Assoc."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0040","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/alz.13653","article-title":"Plasma biomarkers of Alzheimer\u2019s disease in the continuum of dementia with Lewy bodies","volume":"20","author":"Diaz-Galvan","year":"2024","journal-title":"Alzheimers Dement (Amst)."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0045","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1177\/0271678X231172520","article-title":"Quantification and prospective evaluation of serum NfL and GFAP as blood-derived biomarkers of outcome in acute ischemic stroke patients","volume":"43","author":"Ferrari","year":"2023","journal-title":"J. Cereb. Blood Flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0050","doi-asserted-by":"crossref","first-page":"15576","DOI":"10.1007\/s12035-025-05219-3","article-title":"The role of glial fibrillary acidic protein in the neuropathology of Alzheimer\u2019s disease and its potential as a blood biomarker for early diagnosis and progression","volume":"62","author":"Bandara","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0055","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-025-05634-6","article-title":"Circulating vesicular biomarkers in Alzheimer\u2019s disease: from mechanistic insights to clinical applications","volume":"63","author":"Patil","year":"2026","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2025.112960","article-title":"Neurodegeneration and glial activation related blood biomarkers in Alzheimer\u2019s disease: a systematic review and an updated meta-analysis","volume":"212","author":"Ebrahimi","year":"2025","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0065","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209537","article-title":"Blood astrocyte biomarkers in Alzheimer disease: a systematic review and meta-analysis","volume":"103","author":"Holper","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0070","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1006\/neur.1995.0021","article-title":"Synapse loss and gliosis in the molecular layer of the cerebral cortex in Alzheimer\u2019s disease and in frontal lobe degeneration","volume":"4","author":"Brun","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0075","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.3390\/cells11121885","article-title":"Innate immune cell death in neuroinflammation and Alzheimer\u2019s disease","volume":"11","author":"Rajesh","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semcdb.2022.05.028","article-title":"Synapse pathology in Alzheimer\u2019s disease","volume":"139","author":"Griffiths","year":"2023","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0085","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuron.2009.03.024","article-title":"Neurodegenerative diseases target large-scale human brain networks","volume":"62","author":"Seeley","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0090","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70060","article-title":"The early diagnosis of Alzheimer\u2019s disease: blood-based panel biomarker discovery by proteomics and metabolomics","volume":"30","author":"Dong","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0095","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/jcbfm.2015.164","article-title":"The neuropathology and cerebrovascular mechanisms of dementia","volume":"36","author":"Raz","year":"2016","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0100","doi-asserted-by":"crossref","first-page":"6224","DOI":"10.3390\/ijms23116224","article-title":"Neuroinflammation in vascular cognitive impairment and dementia: current evidence, advances, and prospects","volume":"23","author":"Tian","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0105","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","article-title":"The pathobiology of vascular dementia","volume":"80","author":"Iadecola","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s40478-023-01590-1","article-title":"Chronic cerebral hypoperfusion: a critical feature in unravelling the etiology of vascular cognitive impairment","volume":"11","author":"Rajeev","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0115","first-page":"250","article-title":"Vascular dementia: diagnostic criteria for research studies","volume":"43","author":"Rom\u00e1n","year":"1993","journal-title":"Report of the NINDS"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0120","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1017\/S0033291713000494","article-title":"The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies","volume":"44","author":"Vann Jones","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0125","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0130","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1474-4422(21)00341-0","article-title":"Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations","volume":"21","author":"Boeve","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0135","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s43587-023-00565-0","article-title":"Plasma proteomic profiles predict future dementia in healthy adults","volume":"4","author":"Guo","year":"2024","journal-title":"Nat. Aging"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0140","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12916-024-03418-8","article-title":"Peripheral GFAP and NfL as early biomarkers for dementia: longitudinal insights from the UK biobank","volume":"22","author":"Wang","year":"2024","journal-title":"BMC Med."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0145","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/s41591-023-02505-2","article-title":"Emerging diagnostics and therapeutics for Alzheimer disease","volume":"29","author":"Self","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0150","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative accuracy of plasma Phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0155","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jamaneurol.2024.2619","article-title":"Plasma phosphorylated tau 217 and A\u03b242\/40 to predict early brain a\u03b2 accumulation in people without cognitive impairment","volume":"81","author":"Janelidze","year":"2024","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0160","article-title":"Diagnostic accuracy of phosphorylated tau217 in detecting Alzheimer\u2019s disease pathology among cognitively impaired and unimpaired: a systematic review and meta-analysis","volume":"21","author":"Khalafi","year":"2025","journal-title":"Alzheimers Dement. J. Alzheimers Assoc."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0165","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1038\/s41591-022-02074-w","article-title":"Differential roles of A\u03b242\/40, p-tau231 and p-tau217 for Alzheimer\u2019s trial selection and disease monitoring","volume":"28","author":"Ashton","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaneurol.2021.3671","article-title":"Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum","volume":"78","author":"Benedet","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0175","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13195-024-01457-0","article-title":"Serum and cerebrospinal fluid neurofilament light chain and glial fibrillary acid protein levels in early and advanced stages of cerebral amyloid Angiopathy","volume":"16","author":"Rasing","year":"2024","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0180","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41398-020-01137-1","article-title":"Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer\u2019s disease","volume":"11","author":"Chatterjee","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0185","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","article-title":"Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts","volume":"19","author":"Karikari","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0190","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/brain\/awaa399","article-title":"Time course of phosphorylated-tau181 in blood across the Alzheimer\u2019s disease spectrum","volume":"144","author":"Moscoso","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0195","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","article-title":"Plasma P-tau181 in Alzheimer\u2019s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer\u2019s dementia","volume":"26","author":"Janelidze","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0200","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1474-4422(21)00214-3","volume":"20","author":"Thijssen","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0205","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1038\/s41467-021-23620-z","article-title":"A multicentre validation study of the diagnostic value of plasma neurofilament light","volume":"12","author":"Ashton","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0210","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1002\/alz.13318","article-title":"PREVENT-AD research group, longitudinal blood biomarker trajectories in preclinical Alzheimer\u2019s disease","volume":"19","author":"Yakoub","year":"2023","journal-title":"Alzheimers Dement. J. Alzheimers Assoc."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0215","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.ajpath.2021.07.003","article-title":"Interplay between brain Pericytes and endothelial cells in dementia","volume":"191","author":"Procter","year":"2021","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2025.115619","article-title":"Colchicine alleviates ischemic white matter lesions and cognitive deficits by inhibiting microglia inflammation via the TAK1\/MAPK\/NF-\u03baB signaling pathway","volume":"490","author":"Liu","year":"2025","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0225","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70422","article-title":"Blood-brain barrier (BBB) dysfunction in CNS diseases: paying attention to Pericytes","volume":"31","author":"Yu","year":"2025","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0230","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/apha.12250","article-title":"The neurovascular unit - concept review","volume":"210","author":"Muoio","year":"2014","journal-title":"Acta Physiol (Oxf.)"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0235","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3389\/fimmu.2020.01024","article-title":"Interaction of microglia and astrocytes in the neurovascular unit","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0240","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0245","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.it.2020.07.007","article-title":"The role of astrocytes in CNS inflammation","volume":"41","author":"Giovannoni","year":"2020","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0250","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.immuni.2021.01.013","article-title":"Astrocyte-immune cell interactions in physiology and pathology","volume":"54","author":"Han","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0255","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11357-019-00140-9","article-title":"Astrocyte senescence contributes to cognitive decline","volume":"42","author":"Csipo","year":"2020","journal-title":"GeroScience"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045069","article-title":"Astrocyte senescence as a component of Alzheimer\u2019s disease","volume":"7","author":"Bhat","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0265","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1523\/JNEUROSCI.1333-22.2023","article-title":"Targeting astrocyte signaling alleviates cerebrovascular and synaptic function deficits in a diet-based mouse model of small cerebral vessel disease","volume":"43","author":"Sompol","year":"2023","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0270","first-page":"1521","article-title":"Calcineurin proteolysis in astrocytes: implications for impaired synaptic function","volume":"2016","author":"Pleiss","year":"1862","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0275","doi-asserted-by":"crossref","first-page":"12957","DOI":"10.1523\/JNEUROSCI.1064-09.2009","article-title":"Cognitive decline in Alzheimer\u2019s disease is associated with selective changes in calcineurin\/NFAT signaling","volume":"29","author":"Abdul","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0280","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/biom14010129","article-title":"Hydrogen sulfide (H2S)\/Polysulfides (H2Sn) Signalling and TRPA1 channels modification on sulfur metabolism","volume":"14","author":"Kimura","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0285","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adh0102","article-title":"The astrocytic TRPA1 channel mediates an intrinsic protective response to vascular cognitive impairment via LIF production","volume":"9","author":"Kakae","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0290","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1152\/physrev.00022.2020","article-title":"Regulation of cerebral blood flow in humans: physiology and clinical implications of autoregulation","volume":"101","author":"Claassen","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fnetp.2023.1162757","article-title":"Two decades of astrocytes in neurovascular coupling","volume":"3","author":"Lia","year":"2023","journal-title":"Front. Netw. Physiol."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.729201","article-title":"Nitric oxide pathways in neurovascular coupling under Normal and stress conditions in the brain: strategies to rescue aberrant coupling and improve cerebral blood flow","volume":"12","author":"Louren\u00e7o","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0305","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00429-024-02763-x","article-title":"Entorhinal cortex astrocytic atrophy in human frontotemporal dementia","volume":"229","author":"Rodr\u00edguez","year":"2024","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0310","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad158","article-title":"Astrocyte dysfunction and neuronal network hyperactivity in a CRISPR engineered pluripotent stem cell model of frontotemporal dementia","volume":"5","author":"Canals","year":"2023","journal-title":"Brain Commun."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0315","article-title":"14\u20133-3\u03c3 up-regulation in the temporal cortex associates with tau pathology and reactive astroglia in Lewy body disorders","author":"Marsal-Garc\u00eda","year":"2025","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0325","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.pneurobio.2011.01.005","article-title":"GFAP in health and disease","volume":"93","author":"Middeldorp","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceb.2024.102340","article-title":"GFAP-isoforms in the nervous system: understanding the need for diversity","volume":"87","author":"De Reus","year":"2024","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0335","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1023\/A:1007677003387","article-title":"Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000)","volume":"25","author":"Eng","year":"2000","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0340","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tins.2015.04.003","article-title":"Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker","volume":"38","author":"Yang","year":"2015","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0345","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jare.2022.02.015","article-title":"A natural carotenoid crocin exerts antidepressant action by promoting adult hippocampal neurogenesis through Wnt\/\u03b2-catenin signaling","volume":"43","author":"Tao","year":"2023","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0350","doi-asserted-by":"crossref","first-page":"943","DOI":"10.14336\/AD.2021.1029","article-title":"Blocking C3d+\/GFAP+ A1 astrocyte conversion with Semaglutide attenuates blood-brain barrier disruption in mice after ischemic stroke","volume":"13","author":"Zhang","year":"2022","journal-title":"Aging Dis."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0355","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.3390\/cells10071694","article-title":"Alpha-Synuclein preformed fibrils induce cellular senescence in Parkinson\u2019s disease models","volume":"10","author":"Verma","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0360","doi-asserted-by":"crossref","DOI":"10.1177\/1759091420981206","article-title":"Regulation of GFAP expression","volume":"13","author":"Brenner","year":"2021","journal-title":"ASN Neuro"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0365","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/(SICI)1098-1136(199607)17:3<195::AID-GLIA2>3.0.CO;2-0","article-title":"Methylation of the glial fibrillary acidic protein gene shows novel biphasic changes during brain development","volume":"17","author":"Teter","year":"1996","journal-title":"Glia"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0370","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/joa.12948","article-title":"Astrogliogenesis in human fetal brain: complex spatiotemporal immunoreactivity patterns of GFAP, S100, AQP4 and YKL-40","volume":"235","author":"Holst","year":"2019","journal-title":"J. Anat."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0375","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/jnr.23620","article-title":"Mass spectrometric identification of citrullination sites and immunohistochemical detection of citrullinated glial fibrillary acidic protein in Alzheimer\u2019s disease brains","volume":"93","author":"Ishigami","year":"2015","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0380","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1007\/s11064-012-0774-5","article-title":"Phosphorylation of GFAP is associated with injury in the neonatal pig hypoxic-ischemic brain","volume":"37","author":"Sullivan","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109048","article-title":"Reactive astrocytes facilitate vascular repair and remodeling after stroke","volume":"35","author":"Williamson","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0390","doi-asserted-by":"crossref","first-page":"8186","DOI":"10.1523\/JNEUROSCI.4267-13.2014","article-title":"Astrocyte-derived BDNF supports myelin protein synthesis after cuprizone-induced demyelination","volume":"34","author":"Fulmer","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0395","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/biom12020222","article-title":"Neuroinflammation is associated with GFAP and sTREM2 levels in multiple sclerosis","volume":"12","author":"Azzolini","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0400","doi-asserted-by":"crossref","first-page":"8480","DOI":"10.7150\/thno.60031","article-title":"Astrocytic YAP protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model through TGF-\u03b2 signaling","volume":"11","author":"Wu","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0405","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1474-4422(22)00256-3","article-title":"TRACK-TBI study Investigators, prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study","volume":"21","author":"Korley","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0410","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2023.1094503","article-title":"Striatal spatial heterogeneity, clustering, and white matter association of GFAP+ astrocytes in a mouse model of Huntington\u2019s disease","volume":"17","author":"Brown","year":"2023","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0415","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209506","article-title":"Fluid biomarkers in individuals at risk for genetic prion disease up to disease conversion","volume":"103","author":"Vallabh","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0420","article-title":"Emergence delirium and postoperative delirium associated with high plasma NfL and GFAP: an observational study","volume":"10","author":"Liu","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0425","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1089\/neu.2022.0326","article-title":"Trajectory of serum levels of glial fibrillary acidic protein within four weeks post-injury is related to neurological recovery during the transition from acute to chronic spinal cord injury","volume":"40","author":"Leister","year":"2023","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0430","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1001\/jamaneurol.2016.0039","article-title":"Time course and diagnostic accuracy of glial and neuronal blood biomarkers GFAP and UCH-L1 in a large cohort of trauma patients with and without mild traumatic brain injury","volume":"73","author":"Papa","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0435","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13195-020-00682-7","article-title":"Combination of plasma amyloid beta(1-42\/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology","volume":"12","author":"Verberk","year":"2020","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0440","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.annemergmed.2011.08.021","article-title":"Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention","volume":"59","author":"Papa","year":"2012","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0445","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0450","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13195-023-01314-6","article-title":"Biomarkers in Alzheimer\u2019s disease: role in early and differential diagnosis and recognition of atypical variants","volume":"15","author":"Dubois","year":"2023","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0455","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s12276-019-0250-2","article-title":"Diagnosis of Alzheimer\u2019s disease utilizing amyloid and tau as fluid biomarkers","volume":"51","author":"Lee","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0460","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","article-title":"Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for Alzheimer disease pathology","volume":"81","author":"Ashton","year":"2024","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0465","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2174\/1570159X18666200528142429","article-title":"Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer\u2019s disease","volume":"18","author":"Khan","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0470","doi-asserted-by":"crossref","first-page":"17513","DOI":"10.1073\/pnas.0602841103","article-title":"Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury","volume":"103","author":"Wilhelmsson","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0475","first-page":"37","article-title":"Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG","volume":"53","author":"Carter","year":"2012","journal-title":"J. Nucl. Med. Off. Publ. Soc. Nucl. Med."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0480","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13195-024-01459-y","article-title":"Alzheimer\u2019s and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline","volume":"16","author":"Dark","year":"2024","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0485","doi-asserted-by":"crossref","first-page":"e1108","DOI":"10.1212\/WNL.0000000000207602","article-title":"As the Japan prospective studies collaboration for aging and dementia (JPSC-AD) study, association between frequency of social contact and brain atrophy in community-dwelling older people without dementia: the JPSC-AD study","volume":"101","author":"Hirabayashi","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0490","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/alz.12614","article-title":"Association of plasma biomarkers, p-tau181, glial fibrillary acidic protein, and neurofilament light, with intermediate and long-term clinical Alzheimer\u2019s disease risk: results from a prospective cohort followed over 17 years","volume":"19","author":"Stocker","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0495","first-page":"3505","article-title":"Plasma GFAP is an early marker of amyloid-\u03b2 but not tau pathology in Alzheimer\u2019s disease, brain","volume":"144","author":"Pereira","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0500","article-title":"Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer\u2019s disease and vascular pathology","volume":"14","author":"Shir","year":"2022","journal-title":"Alzheimers Dement. Diagn. Assess. Dis. Monit."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0505","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/clinchem\/hvad018","article-title":"Plasma glial fibrillary acidic protein in the Alzheimer disease continuum: relationship to other biomarkers, differential diagnosis, and prediction of clinical progression","volume":"69","author":"Shen","year":"2023","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0510","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3390\/cells12091309","article-title":"GFAP as a potential biomarker for Alzheimer\u2019s disease: a systematic review and Meta-analysis","volume":"12","author":"Kim","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0515","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/S0140-6736(15)00463-8","article-title":"Vascular dementia","volume":"386","author":"O\u2019Brien","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0520","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12974-021-02234-8","article-title":"Attenuating vascular stenosis-induced astrogliosis preserves white matter integrity and cognitive function","volume":"18","author":"Liu","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0525","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.70210","article-title":"Clinical utility of plasma GFAP and NEFL as biomarkers for dementia in the community","volume":"169","author":"Li","year":"2025","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0530","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209452","article-title":"Intrinsic capacity, polygenic risk score, APOE genotype, and risk of dementia: a prospective cohort study based on the UK biobank","volume":"102","author":"Sun","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0535","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-56756-3","article-title":"Performance of plasma biomarkers for diagnosis and prediction of dementia in a Brazilian cohort","volume":"16","author":"Santos","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0540","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/jnnp-2019-321954","article-title":"GENFI, plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia","volume":"91","author":"Heller","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0545","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/glia.23091","article-title":"Progranulin protects against exaggerated axonal injury and astrogliosis following traumatic brain injury","volume":"65","author":"Menzel","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0550","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.3233\/JAD-170989","article-title":"Novel GRN mutations in Alzheimer\u2019s disease and frontotemporal lobar degeneration","volume":"62","author":"Piaceri","year":"2018","journal-title":"J. Alzheimers Dis. JAD"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0555","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neuroscience.2015.12.006","article-title":"Core neuropathological abnormalities in progranulin-deficient mice are penetrant on multiple genetic backgrounds","volume":"315","author":"Petkau","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0560","doi-asserted-by":"crossref","DOI":"10.1038\/srep42991","article-title":"Astrocyte pathology in a human neural stem cell model of frontotemporal dementia caused by mutant TAU protein","volume":"7","author":"Hallmann","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0565","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/ajmg.b.32443","article-title":"Unusually long duration and delayed penetrance in a family with FTD and mutation in MAPT (V337M)","volume":"174","author":"Domoto-Reilly","year":"2017","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet. Off. Publ. Int. Soc. Psychiatr. Genet."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0570","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/jnnp-2021-327788","article-title":"Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer\u2019s disease, frontotemporal dementia and progressive supranuclear palsy","volume":"93","author":"Chouliaras","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0575","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41591-020-0762-2","article-title":"Advancing research and treatment for frontotemporal lobar degeneration (ARTFL) investigators, diagnostic value of plasma phosphorylated tau181 in Alzheimer\u2019s disease and frontotemporal lobar degeneration","volume":"26","author":"Thijssen","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0580","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s13195-024-01647-w","article-title":"Blood-based biomarkers and plasma a\u03b2 assays in the differential diagnosis of Alzheimer\u2019s disease and behavioral-variant frontotemporal dementia","volume":"16","author":"Mohaupt","year":"2024","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.disamonth.2022.101441","article-title":"Recent advances in Lewy body dementia: a comprehensive review","volume":"69","author":"Prasad","year":"2023","journal-title":"Dis. Mon."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0590","doi-asserted-by":"crossref","DOI":"10.1017\/neu.2025.15","article-title":"Systematic review of differentially abundant proteins in people with Lewy body dementia","volume":"37","author":"Farr","year":"2025","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0595","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.parkreldis.2022.07.008","article-title":"The relationship between plasma biomarkers and amyloid PET in dementia with Lewy bodies","volume":"101","author":"Donaghy","year":"2022","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0600","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13195-024-01502-y","article-title":"Plasma biomarkers of amyloid, tau, axonal, and neuroinflammation pathologies in dementia with Lewy bodies","volume":"16","author":"Vrillon","year":"2024","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0605","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/jnc.13399","article-title":"Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer\u2019s disease, dementia with Lewy bodies, and frontotemporal lobar degeneration","volume":"136","author":"Ishiki","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0610","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3233\/JAD-180325","article-title":"Glial fibrillary acidic protein in serum is increased in Alzheimer\u2019s disease and correlates with cognitive impairment","volume":"67","author":"Oeckl","year":"2019","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0615","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13195-022-01093-6","article-title":"Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias","volume":"14","author":"Baiardi","year":"2022","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0620","first-page":"3325","article-title":"Clinical and diagnostic implications of Alzheimer\u2019s disease copathology in Lewy body disease, brain","volume":"147","author":"Barba","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0625","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13195-025-01712-y","article-title":"Evaluating the diagnostic performance of six plasma biomarkers for Alzheimer\u2019s disease and other neurodegenerative dementias in a large Chinese cohort","volume":"17","author":"Jiao","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0630","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13195-023-01340-4","article-title":"Clinical and biological relevance of glial fibrillary acidic protein in Alzheimer\u2019s disease","volume":"15","author":"Yang","year":"2023","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0635","article-title":"Differential diagnostic performance of a panel of plasma biomarkers for different types of dementia","volume":"14","author":"Thijssen","year":"2022","journal-title":"Alzheimers Dement. Diagn. Assess. Dis. Monit."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0640","article-title":"Combined use of plasma p-tau217, NfL, and GFAP predicts domain-specific cognitive decline in cognitively unimpaired and MCI individuals","volume":"21","author":"Wu","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0645","doi-asserted-by":"crossref","first-page":"945","DOI":"10.12669\/pjms.344.15363","article-title":"Dynamic changes and clinical significance of serum S100B protein and glial fibrillary acidic protein in patients with delayed encephalopathy after acute carbon monoxide poisoning","volume":"34","author":"Di","year":"2018","journal-title":"Pak. J. Med. Sci."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0650","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1034\/j.1399-6576.2002.460512.x","article-title":"Biochemical markers for brain damage after cardiac surgery -- time profile and correlation with cognitive dysfunction","volume":"46","author":"Rasmussen","year":"2002","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0655","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1089\/neu.2017.5046","article-title":"Prospective assessment of acute blood markers of brain injury in sport-related concussion","volume":"34","author":"Meier","year":"2017","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0660","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13195-020-00682-7","article-title":"Combination of plasma amyloid beta(1-42\/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology","volume":"12","author":"Verberk","year":"2020","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0665","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/S2666-7568(20)30061-1","article-title":"Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study","volume":"2","author":"Verberk","year":"2021","journal-title":"Lancet Healthy Longev."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0670","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/ana.25874","article-title":"Remote blood biomarkers of longitudinal cognitive outcomes in a population study","volume":"88","author":"Rajan","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0675","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/alz.12639","article-title":"Examining the association between blood-based biomarkers and human post-mortem neuropathology in the University of Kentucky Alzheimer\u2019s disease research center autopsy cohort","volume":"19","author":"Winder","year":"2023","journal-title":"Alzheimers Dement. J. Alzheimers Assoc."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0680","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202217123","article-title":"Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads","volume":"15","author":"Salvad\u00f3","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0685","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00401-023-02594-w","article-title":"Plasma biomarkers for prediction of Alzheimer\u2019s disease neuropathologic change","volume":"146","author":"Bermudez","year":"2023","journal-title":"Acta Neuropathol. (Berl.)"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0690","first-page":"1171","article-title":"The use of tau PET to stage Alzheimer disease according to the Braak staging framework","volume":"64","author":"Macedo","year":"2023","journal-title":"J. Nucl. Med. Off. Publ. Soc. Nucl. Med."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0695","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/brain\/awae035","article-title":"Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles","volume":"147","author":"S\u00e1nchez-Juan","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.tjpad.2024.100011","article-title":"Informing etiological heterogeneity of mild cognitive impairment and risk for progression to dementia with plasma p-tau217","volume":"12","author":"Asken","year":"2025","journal-title":"J. Prev Alzheimers Dis."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0705","article-title":"Crossing pathological boundaries: multi-target restoration of the neurovascular unit in Alzheimer\u2019s and vascular dementia-from modern therapeutics to traditional Chinese medicine","author":"Zhao","year":"2025","journal-title":"Aging Dis."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0710","doi-asserted-by":"crossref","DOI":"10.1177\/13872877251375476","article-title":"Neurovascular coupling dysfunction associated with cognition and glial fibrillary acidic protein along the Alzheimer\u2019s disease continuum","author":"Chen","year":"2025","journal-title":"J. Alzheimer\u2019s Dis"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0715","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41531-023-00447-7","article-title":"Plasma GFAP in Parkinson\u2019s disease with cognitive impairment and its potential to predict conversion to dementia","volume":"9","author":"Tang","year":"2023","journal-title":"NPJ Park. Dis."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2023.148271","article-title":"Association of serum neurofilament light chain and glial fibrillary acidic protein levels with cognitive decline in Parkinson\u2019s disease","volume":"1805","author":"Mao","year":"2023","journal-title":"Brain Res."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0725","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","article-title":"Parkinson\u2019s disease and parkinsonism","volume":"132","author":"Hayes","year":"2019","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0730","doi-asserted-by":"crossref","first-page":"783","DOI":"10.3233\/JPD-150682","article-title":"Associations between cerebrospinal fluid biomarkers and cognition in early untreated Parkinson\u2019s disease","volume":"5","author":"Skogseth","year":"2015","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0735","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12974-023-02843-5","article-title":"Cerebrospinal fluid GFAP is a predictive biomarker for conversion to dementia and Alzheimer\u2019s disease-associated biomarkers alterations among de novo Parkinson\u2019s disease patients: a prospective cohort study","volume":"20","author":"Liu","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0740","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nn.4288","article-title":"Pericytes of the neurovascular unit: key functions and signaling pathways","volume":"19","author":"Sweeney","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0745","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0750","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2","volume":"4","author":"Iliff","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0755","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1002\/alz.12806","article-title":"Differences between blood and cerebrospinal fluid glial fibrillary acidic protein levels: the effect of sample stability","volume":"18","author":"Simr\u00e9n","year":"2022","journal-title":"Alzheimers Dement. J. Alzheimers Assoc."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0760","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/alz.12724","article-title":"AIBL research group, plasma A\u03b242\/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer\u2019s disease continuum: a cross-sectional and longitudinal study in the AIBL cohort","volume":"19","author":"Chatterjee","year":"2023","journal-title":"Alzheimers Dement. J. Alzheimers Assoc."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0765","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3390\/biomedicines12061253","article-title":"SIMOA diagnostics on Alzheimer\u2019s disease and frontotemporal dementia","volume":"12","author":"Chatziefstathiou","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0770","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1001\/jama.2024.6619","article-title":"Changes in Alzheimer disease blood biomarkers and associations with incident all-cause dementia","volume":"332","author":"Lu","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0775","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1375302","article-title":"Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia","volume":"15","author":"Ingannato","year":"2024","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0780","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.3390\/bios12121165","article-title":"Ultrasensitive determination of glial-fibrillary-acidic-protein (GFAP) in human serum-matrix with a label-free Impedimetric Immunosensor","volume":"12","author":"Ozcelikay","year":"2022","journal-title":"Biosensors"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0785","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000210225","article-title":"Blood-based biomarkers and risk of onset of mild cognitive impairment over the short and long term","volume":"104","author":"Soldan","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0790","doi-asserted-by":"crossref","first-page":"8134","DOI":"10.3390\/ijms26178134","article-title":"Fully automated measurement of GFAP in CSF using the LUMIPULSE\u00ae system: implications for Alzheimer\u2019s disease diagnosis and staging","volume":"26","author":"Nojima","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0795","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13195-022-01113-5","article-title":"Multi-platform proteomic analysis of Alzheimer\u2019s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome","volume":"14","author":"Dammer","year":"2022","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0800","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.1007\/s00415-024-12669-7","article-title":"Plasma NfL, GFAP, amyloid, and p-tau species as prognostic biomarkers in Parkinson\u2019s disease","volume":"271","author":"Pilotto","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0805","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106356","article-title":"Trajectories of CSF and plasma biomarkers across Alzheimer\u2019s disease continuum: disease staging by NF-L, p-tau181, and GFAP","volume":"189","author":"Wojda\u0142a","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0810","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/alz.13560","article-title":"Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: results from the Ontario neurodegenerative disease research Initiative","volume":"20","author":"Sanchez","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0815","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13024-024-00750-8","article-title":"Astrocyte reactivity is associated with tau tangle load and cortical thinning in Alzheimer\u2019s disease","volume":"19","author":"Guo","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ijbiomac.2026.151452_bb0820","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13024-024-00753-5","article-title":"Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer\u2019s disease","volume":"19","author":"Zeng","year":"2024","journal-title":"Mol. Neurodegener."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026013784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026013784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:05:13Z","timestamp":1776258313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026013784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":163,"alternative-id":["S0141813026013784"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.151452","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of astrocyte biomarker GFAP in early diagnosis and prognosis assessment of dementia: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.151452","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151452"}}